Logo image of ASLE

AERSALE CORP (ASLE) Stock Fundamental Analysis

NASDAQ:ASLE - Nasdaq - US00810F1066 - Common Stock - Currency: USD

6.9  +0.02 (+0.29%)

After market: 6.9 0 (0%)

Fundamental Rating

3

ASLE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 66 industry peers in the Aerospace & Defense industry. While ASLE seems to be doing ok healthwise, there are quite some concerns on its profitability. ASLE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ASLE was profitable.
ASLE had a negative operating cash flow in the past year.
ASLE had positive earnings in 4 of the past 5 years.
In the past 5 years ASLE reported 4 times negative operating cash flow.
ASLE Yearly Net Income VS EBIT VS OCF VS FCFASLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 50M -50M -100M -150M

1.2 Ratios

ASLE has a Return On Assets of 0.07%. This is in the lower half of the industry: ASLE underperforms 62.50% of its industry peers.
Looking at the Return On Equity, with a value of 0.09%, ASLE is in line with its industry, outperforming 40.63% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.51%, ASLE is doing worse than 65.63% of the companies in the same industry.
Industry RankSector Rank
ROA 0.07%
ROE 0.09%
ROIC 0.51%
ROA(3y)4.89%
ROA(5y)3.48%
ROE(3y)5.81%
ROE(5y)4.08%
ROIC(3y)N/A
ROIC(5y)N/A
ASLE Yearly ROA, ROE, ROICASLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 2 4 6 8

1.3 Margins

ASLE's Profit Margin of 0.12% is on the low side compared to the rest of the industry. ASLE is outperformed by 60.94% of its industry peers.
ASLE has a worse Operating Margin (1.09%) than 65.63% of its industry peers.
The Gross Margin of ASLE (28.60%) is better than 70.31% of its industry peers.
ASLE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.09%
PM (TTM) 0.12%
GM 28.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.01%
GM growth 5YN/A
ASLE Yearly Profit, Operating, Gross MarginsASLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 20 30

4

2. Health

2.1 Basic Checks

ASLE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ASLE has more shares outstanding
The number of shares outstanding for ASLE has been increased compared to 5 years ago.
The debt/assets ratio for ASLE is higher compared to a year ago.
ASLE Yearly Shares OutstandingASLE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
ASLE Yearly Total Debt VS Total AssetsASLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.96 indicates that ASLE is not a great score, but indicates only limited risk for bankruptcy at the moment.
ASLE has a Altman-Z score (2.96) which is in line with its industry peers.
A Debt/Equity ratio of 0.17 indicates that ASLE is not too dependend on debt financing.
ASLE has a better Debt to Equity ratio (0.17) than 76.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 2.96
ROIC/WACC0.06
WACC9.28%
ASLE Yearly LT Debt VS Equity VS FCFASLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

A Current Ratio of 7.21 indicates that ASLE has no problem at all paying its short term obligations.
ASLE's Current ratio of 7.21 is amongst the best of the industry. ASLE outperforms 98.44% of its industry peers.
ASLE has a Quick Ratio of 1.61. This is a normal value and indicates that ASLE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.61, ASLE is in the better half of the industry, outperforming 65.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.21
Quick Ratio 1.61
ASLE Yearly Current Assets VS Current LiabilitesASLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 100M 200M 300M

4

3. Growth

3.1 Past

The earnings per share for ASLE have decreased strongly by -75.00% in the last year.
Looking at the last year, ASLE shows a small growth in Revenue. The Revenue has grown by 2.85% in the last year.
Measured over the past years, ASLE shows a quite strong growth in Revenue. The Revenue has been growing by 16.99% on average per year.
EPS 1Y (TTM)-75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)2.85%
Revenue growth 3Y16.99%
Revenue growth 5YN/A
Sales Q2Q%-10.6%

3.2 Future

The Earnings Per Share is expected to grow by 100.52% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.49% on average over the next years.
EPS Next Y138%
EPS Next 2Y134.28%
EPS Next 3Y100.52%
EPS Next 5YN/A
Revenue Next Year-16.14%
Revenue Next 2Y-0.99%
Revenue Next 3Y5.49%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ASLE Yearly Revenue VS EstimatesASLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ASLE Yearly EPS VS EstimatesASLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 86.25 indicates a quite expensive valuation of ASLE.
ASLE's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 29.63. ASLE is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 17.96, the valuation of ASLE can be described as rather expensive.
ASLE's Price/Forward Earnings ratio is rather cheap when compared to the industry. ASLE is cheaper than 82.81% of the companies in the same industry.
ASLE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 86.25
Fwd PE 17.96
ASLE Price Earnings VS Forward Price EarningsASLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ASLE.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.83
ASLE Per share dataASLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

ASLE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ASLE's earnings are expected to grow with 100.52% in the coming years.
PEG (NY)0.63
PEG (5Y)N/A
EPS Next 2Y134.28%
EPS Next 3Y100.52%

0

5. Dividend

5.1 Amount

No dividends for ASLE!.
Industry RankSector Rank
Dividend Yield N/A

AERSALE CORP

NASDAQ:ASLE (2/21/2025, 8:01:56 PM)

After market: 6.9 0 (0%)

6.9

+0.02 (+0.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-17 2025-03-17/amc
Inst Owners45.25%
Inst Owner Change-90.93%
Ins Owners7.3%
Ins Owner Change1.57%
Market Cap367.15M
Analysts77.78
Price Target8.16 (18.26%)
Short Float %6.44%
Short Ratio7.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-87.74%
Min EPS beat(2)-149.02%
Max EPS beat(2)-26.47%
EPS beat(4)1
Avg EPS beat(4)-31.52%
Min EPS beat(4)-149.02%
Max EPS beat(4)153.75%
EPS beat(8)2
Avg EPS beat(8)-45.49%
EPS beat(12)5
Avg EPS beat(12)5.64%
EPS beat(16)9
Avg EPS beat(16)74.52%
Revenue beat(2)0
Avg Revenue beat(2)-12.96%
Min Revenue beat(2)-13.25%
Max Revenue beat(2)-12.68%
Revenue beat(4)1
Avg Revenue beat(4)-15.7%
Min Revenue beat(4)-40.8%
Max Revenue beat(4)3.91%
Revenue beat(8)1
Avg Revenue beat(8)-17.52%
Revenue beat(12)4
Avg Revenue beat(12)-7.79%
Revenue beat(16)6
Avg Revenue beat(16)15.43%
PT rev (1m)0%
PT rev (3m)4.35%
EPS NQ rev (1m)-29.03%
EPS NQ rev (3m)-29.03%
EPS NY rev (1m)-18.33%
EPS NY rev (3m)-20.97%
Revenue NQ rev (1m)-4.15%
Revenue NQ rev (3m)-4.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.3%
Valuation
Industry RankSector Rank
PE 86.25
Fwd PE 17.96
P/S 1.06
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.89
EV/EBITDA 24.83
EPS(TTM)0.08
EY1.16%
EPS(NY)0.38
Fwd EY5.57%
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS6.48
BVpS8.49
TBVpS7.72
PEG (NY)0.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.07%
ROE 0.09%
ROCE 0.68%
ROIC 0.51%
ROICexc 0.52%
ROICexgc 0.57%
OM 1.09%
PM (TTM) 0.12%
GM 28.6%
FCFM N/A
ROA(3y)4.89%
ROA(5y)3.48%
ROE(3y)5.81%
ROE(5y)4.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.01%
GM growth 5YN/A
F-Score2
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 4.49
Cap/Depr 89.45%
Cap/Sales 3.59%
Interest Coverage 0.73
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.21
Quick Ratio 1.61
Altman-Z 2.96
F-Score2
WACC9.28%
ROIC/WACC0.06
Cap/Depr(3y)65.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y138%
EPS Next 2Y134.28%
EPS Next 3Y100.52%
EPS Next 5YN/A
Revenue 1Y (TTM)2.85%
Revenue growth 3Y16.99%
Revenue growth 5YN/A
Sales Q2Q%-10.6%
Revenue Next Year-16.14%
Revenue Next 2Y-0.99%
Revenue Next 3Y5.49%
Revenue Next 5YN/A
EBIT growth 1Y697.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year74.64%
EBIT Next 3Y55.31%
EBIT Next 5YN/A
FCF growth 1Y-204.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-164.49%
OCF growth 3YN/A
OCF growth 5YN/A